Exocrine pancreatic function in hepatocyte nuclear factor 1 beta;-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: Compensatory hypersecretion from a hypoplastic pancreas

Diabetic Medicine

Volumn 30, Issue 8, 2013, Pages 946-955

  Tjora, E ^a,b   Wathle, G ^b   Erchinger, F ^b   Engjom, T ^b   Molven, A ^a,c   Aksnes, L ^a,b   Haldorsen, I S ^a,b   Dimcevski, G ^b   Raeder H ^a,b   Njolstad P R ^a,b,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; AMYLASE; BICARBONATE; CHYMOTRYPSIN; ELASTASE; HEPATOCYTE NUCLEAR FACTOR 1BETA; RETINOL; SECRETIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ACINAR CELL; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DUODENUM FLUID; ENDOSCOPY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREAS FUNCTION; PANCREAS SECRETION; SCHOOL CHILD; VITAMIN BLOOD LEVEL; WATER FLOW;

ACINAR CELLS; ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DENTAL ENAMEL; DIABETES MELLITUS, TYPE 2; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; KIDNEY DISEASES, CYSTIC; MALE; MIDDLE AGED; MUTATION; ORGAN SIZE; PANCREAS, EXOCRINE; PANCREATIC DUCTS; PANCREATIC JUICE; PEDIGREE; SECRETIN; UP-REGULATION;

EID: 84880657620     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12190     Document Type: Article

References (30)

1. Søvik O, Sagen JV, Njølstad PR. TCF2 (HNF1Β) and MODY5 and Urogenital Malformations. In: Epstein CJ, RO Erickson, A Wynshaw-Boris, eds. Inborn Errors of Development. 2nd edn. New York: Oxford University Press, 2008, pp 1096-1102.
2. Chen YZ, Gao Q, Zhao XZ, Bennett CL, Xiong XS, Mei CL et al. Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5. Chin Med J (Engl) 2010; 123: 3326-3333.
3. Haumaitre C, Barbacci E, Jenny M, Ott MO, Gradwohl G, Cereghini S. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc Natl Acad Sci U S A 2005; 102: 1490-1495.
4. Haumaitre C, Fabre M, Cormier S, Baumann C, Delezoide AL, Cereghini S. Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1beta/MODY5 mutations. Hum Mol Genet 2006; 15: 2363-2375.
5. Haldorsen IS, Vesterhus M, Raeder H, Jensen DK, Sovik O, Molven A et al. Lack of pancreatic body and tail in HNF1B mutation carriers. Diabet Med 2008; 25: 782-787.
6. Pearson ER, Badman MK, Lockwood CR, Clark PM, Ellard S, Bingham C et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. Diabetes Care 2004; 27: 1102-1107.
7. Brackenridge A, Pearson ER, Shojaee-Moradie F, Hattersley AT, Russell-Jones D, Umpleby AM. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations. Diabetes 2006; 55: 405-411.
8. Welters HJ, Senkel S, Klein-Hitpass L, Erdmann S, Thomas H, Harries LW et al. Conditional expression of hepatocyte nuclear factor-1beta, the maturity-onset diabetes of the young-5 gene product, influences the viability and functional competence of pancreatic beta-cells. J Endocrinol 2006; 190: 171-181.
9. Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 2004; 140: 510-517.
10. Gonc EN, Ozturk BB, Haldorsen IS, Molnes J, Immervoll H, Raeder H et al. HNF1B mutation in a Turkish child with renal and exocrine pancreas insufficiency, diabetes and liver disease. Pediatr Diabetes 2012; 13: e1-5.
11. Edghill EL, Bingham C, Slingerland AS, Minton JA, Noordam C, Ellard S et al. Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development. Diabet Med 2006; 23: 1301-1306.
12. Lieb JG2nd, Draganov PV. Pancreatic function testing: here to stay for the 21st century. World J Gastroenterol 2008; 14: 3149-3158.
13. Hahn JU, Kerner W, Maisonneuve P, Lowenfels AB, Lankisch PG. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas 2008; 36: 274-278.
14. Kenkel J. Analytical chemistry for technicians. 3rd edn. Boca Raton, FL: CRC Press LLC, 2003.
15. Punwani S, Gillams AR, Lees WR. Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol 2003; 13: 273-276.
16. Raeder H, Haldorsen IS, Ersland L, Gruner R, Taxt T, Sovik O et al. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes 2007; 56: 444-449.
17. Edghill EL, Oram RA, Owens M, Stals KL, Harries LW, Hattersley AT et al. Hepatocyte nuclear factor-1beta gene deletions-a common cause of renal disease. Nephrol Dial Transplant 2008; 23: 627-635.
18. Pandol S. The exocrine pancreas. San Rafael, CA: Morgan & Claypool Life Sciences 2010.
19. Sanyal R, Stevens T, Novak E, Veniero JC. Secretin-enhanced MRCP: review of technique and application with proposal for quantification of exocrine function. AJR Am J Roentgenol 2012; 198: 124-132.
20. Stevens T, Conwell DL, Zuccaro G Jr, Lewis SA, Love TE. The efficiency of endoscopic pancreatic function testing is optimized using duodenal aspirates at 30 and 45 minutes after intravenous secretin. Am J Gastroenterol 2007; 102: 297-301.
21. Jensen NM, Larsen S. A rapid, endoscopic exocrine pancreatic function test and the Lundh test: a comparative study. Pancreatology 2008; 8: 617-624.
22. Stevens T, Parsi MA. Update on endoscopic pancreatic function testing. World J Gastroenterol 2011; 17: 3957-3961.
23. Haldorsen IS, Raeder H, Vesterhus M, Molven A, Njolstad PR. The role of pancreatic imaging in monogenic diabetes mellitus. Nat Rev Endocrinol 2012; 8: 148-159.
24. Philippe MF, Benabadji S, Barbot-Trystram L, Vadrot D, Boitard C, Larger E. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas 2011; 40: 359-363.
25. Higuchi A, Yasugi H, Yokota T, Tobe T, Mizumoto R. Changes of pancreatic exocrine function after major resection of the pancreas in dogs. Gastroenterol Jpn 1979; 14: 316-326.
26. Erturk SM, Ichikawa T, Motosugi U, Sou H, Araki T. Diffusion-weighted MR imaging in the evaluation of pancreatic exocrine function before and after secretin stimulation. Am J Gastroenterol 2006; 101: 133-136.
27. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79: 362-371.
28. Duggan SN, O'Sullivan M, Hamilton S, Feehan SM, Ridgway PF, Conlon KC. Patients with chronic pancreatitis are at increased risk for osteoporosis. Pancreas 2012; 41: 1119-1124.
29. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813-815.
30. Lankisch PG, Lembcke B, Wemken G, Creutzfeldt W. Functional reserve capacity of the exocrine pancreas. Digestion 1986; 35: 175-181.